Methylation of CDX2 gene promoter in the prediction of treatment efficacy in colorectal cancer

The aim of the present study was to examine the diagnosis of methylation of CDX2 gene promoter in colorectal cancer (CRC) and assessed its value in the prediction of treatment efficacy. Sixty patients who were diagnosed as CRCs for the first time, 60 patients with hyperplastic polyps (HPs) and adeno...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yunshuai, Li, Zhaohui, Li, Wenxian, Liu, Shuaifeng, Han, Baowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006183/
https://www.ncbi.nlm.nih.gov/pubmed/29928401
http://dx.doi.org/10.3892/ol.2018.8670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006183/
https://www.ncbi.nlm.nih.gov/pubmed/29928401
http://dx.doi.org/10.3892/ol.2018.8670

Ejemplares similares